Skip to content

Promore Pharma engages Erik Penser Bank as liquidity provider

STOCKHOLM, 16 August, 2023 — Promore Pharma AB (publ) today announced that the company has entered into an agreement with Erik Penser Bank to act as liquidity provider for the Promore Pharma share starting 21 August 2023. The agreement with ABG Sundal Collier ASA, that currently serves as a liquidity provider will expire at the close of the stock exchange on 18 August 2023.

The liquidity provision assignment is offered in accordance with the rules of Nasdaq Stockholm AB’s and means that the liquidity provider quotes a buy and sell volume corresponding to at least 15,000 SEK, with a maximum spread of 4% between the bid and ask price. The purpose is to promote the liquidity in the trading of the share.